These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22739423)

  • 1. Pharmacogenomic approaches to study the effects of antihypertensive drugs.
    Kamide K; Kawano Y; Rakugi H
    Hypertens Res; 2012 Aug; 35(8):796-9. PubMed ID: 22739423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pharmacogenomic variation of antihypertensive drugs: from population genetics to personalized medicine.
    Polimanti R; Iorio A; Piacentini S; Manfellotto D; Fuciarelli M
    Pharmacogenomics; 2014 Feb; 15(2):157-67. PubMed ID: 24444406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular approaches to individualize antihypertensive drug therapy.
    Hiltunen TP; Kontula K
    Ann Med; 2012 Jun; 44 Suppl 1():S23-9. PubMed ID: 22713145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic basis of hypertension for the development of tailored medicine.
    Katsuya T; Morishita R; Rakugi H; Ogihrara T
    Hypertens Res; 2009 Aug; 32(8):643-8. PubMed ID: 19543233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive pharmacogenetics.
    Nogueira JB
    Rev Port Cardiol; 2004 Dec; 23(12):1621-30. PubMed ID: 15732663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and hypertension: is it time to change my practice?
    Delles C; Padmanabhan S
    Can J Cardiol; 2012 May; 28(3):296-304. PubMed ID: 22482397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacogenetics--pathway to individualized antihypertensive pharmacotherapy].
    Kurland L; Lind L; Lithell H; Syvänen AC; Melhus H
    Lakartidningen; 2003 Feb; 100(8):600-3. PubMed ID: 12640971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of antihypertensive drug response.
    Kreutz R
    Curr Hypertens Rep; 2004 Feb; 6(1):15-20. PubMed ID: 14972084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics considerations in the control of hypertension.
    Lupoli S; Salvi E; Barcella M; Barlassina C
    Pharmacogenomics; 2015 Nov; 16(17):1951-64. PubMed ID: 26555875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of hypertension.
    Cadman PE; O'Connor DT
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):61-70. PubMed ID: 12496668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives.
    Luizon MR; Palei AC; Cavalli RC; Sandrim VC
    Pharmacogenomics; 2017 Apr; 18(6):571-583. PubMed ID: 28358601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of antihypertensive drugs: past, present and future.
    Johnson JA
    Pharmacogenomics; 2010 Apr; 11(4):487-91. PubMed ID: 20350127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenetics and pharmacogenomics. Searching for individual antihypertensive therapy concepts].
    Brand E
    MMW Fortschr Med; 2003 May; 145(19):43-4. PubMed ID: 12813978
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genetics and hypertension].
    Ellervik C; Tarnow L; Pedersen EB
    Ugeskr Laeger; 2009 Jun; 171(24):2012-5. PubMed ID: 19523364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-environment interactions of selected pharmacogenes in arterial hypertension.
    Bochud M; Guessous I
    Expert Rev Clin Pharmacol; 2012 Nov; 5(6):677-86. PubMed ID: 23234325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in common antihypertensive targets: Pharmacogenomic implications for the treatment of cardiovascular disease.
    Brown D; Alcala H; Oelschlaeger P; Andresen BT
    Adv Pharmacol; 2022; 94():141-182. PubMed ID: 35659371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using genotyping to predict responses to anti-hypertensive treatment.
    Kurland L; Lind L; Melhus H
    Trends Pharmacol Sci; 2005 Sep; 26(9):443-7. PubMed ID: 16055200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization Strategies.
    Loganathan L; Gopinath K; Sankaranarayanan VM; Kukreti R; Rajendran K; Lee JK; Muthusamy K
    Curr Drug Targets; 2020; 21(1):18-33. PubMed ID: 31393243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.